DESCRIPTION 

The purpose of this presentation is to describe the benefits of community-based care of substance use disorders (SUDS) in Black and Latinx communities. It will describe Screening Brief Intervention and Referral to Treatment (SBIRT), Medications for Opioid Use Disorder (MOUD), Medications for Addition Treatment (MAT) with a focus on MOUD. Additionally,  late breaking research (e.g., psilocybin to treat mental health and addiction) will be discussed.

LEARNING OBJECTIVES

• To understand the three tenants of Screening Brief Intervention and Referral to Treatment (SBIRT) in detail.
• To review all the FDA approved Medications for Addiction Treatment (MAT) with a focus on Medications for Opioid Use Disorder (MOUD).
• To provide an overview of at least three psychedelics being studied in research to treat mental health illnesses, including substance use disorders.

PRESENTER

Ayana Jordan, MD, PhD, is an Addiction Psychiatrist and the Barbara Wilson Associate Professor of Psychiatry in the Department of Psychiatry, at NYU Grossman School of Medicine and Pillar Co-Lead for the Community Engagement Pillar in the NYU Langone Institute for Excellence in Health Equity.  She is dedicated to creating spaces and opportunities for more people of color, specifically Black women in academia who are vastly underrepresented. The fundamental message of equity and inclusion has informed her research, clinical work and leadership duties at NYU and beyond. 

*CONTACT HOUR ELIGIBILITY

In order to be eligible for the 0.75 contact hours/certificate of attendance, you must join the live webinar in the Zoom platform.

Certificates must be requested within one week of the event and will be processed within 30 days.

If you are having issues accessing the room/application at the time of the event: Please email [email protected] at the start of the webinar so that we can assist you.